{"id":6511,"date":"2024-10-22T20:48:47","date_gmt":"2024-10-22T20:48:47","guid":{"rendered":"https:\/\/prrf.org\/?page_id=6511"},"modified":"2026-04-10T17:00:05","modified_gmt":"2026-04-10T17:00:05","slug":"research","status":"publish","type":"page","link":"https:\/\/prrf.org\/zh\/research\/","title":{"rendered":"\u7814\u7a76"},"content":{"rendered":"
<\/div><\/div><\/div>
\n\t
\n\t\t
\n\t\t\t
\n\t\t\t\t
<\/div> <\/div>
\n\t
\n\t\t
\n\t\t
\n\t\t\t

\u7814\u7a76<\/h1><\/div>\n
\n\t
\n\t\t

For over a decade, the Oakland University Eye Research Institute (ERI) has collaborated with the Pediatric Retinal Research Foundation to advance research in pediatric retinal diseases. This long-standing partnership has now expanded to include the Oakland University William Beaumont School of Medicine (OUWB) Eye Research Center (ERC), established in 2021, further strengthening our commitment to groundbreaking discoveries in pediatric retina research.\u00a0<\/span>\u00a0<\/span><\/p>\n

Through this partnership, we have successfully established the Pediatric Retinal Research Laboratory (PRRL), providing a dedicated space at the ERI\/ERC for innovative studies aimed at understanding and treating pediatric retinal disorders. Additionally, this partnership actively supports the research endeavors of undergraduate and medical students at both Oakland University and OUWB, fostering an excellent training of the next generation of vision scientists and physician-researchers.\u00a0<\/span>\u00a0<\/span><\/p>\n

To further promote excellence in pediatric retinal research, we have also implemented pilot research grants, offering crucial funding to investigators exploring new therapeutic approaches for pediatric retinal diseases. This initiative not only enhances research capabilities at ERI\/ERC but also contributes to the broader mission of improving childhood eye health through scientific discovery and innovation.\u00a0<\/span>\u00a0<\/span><\/p>\n

Together, our institutions remain committed to advancing knowledge, training future leaders, and developing new therapies for pediatric retinal diseases.<\/span><\/b>\u00a0<\/span><\/p>\n\t<\/div>\n<\/div>\n\n\n\n

\n
\n
\n
\n \"\"\n <\/div>\n <\/div>\n <\/div>\n <\/div>\n\t\t<\/div> \n\t<\/div>\n\t<\/div> \n<\/div><\/div>\n\t
\n\t\t
\n\t\t\t